Healthcare-associated pneumonia: A US disease or relevant to the Asia Pacific, too?

Respirology

Volumn 18, Issue 6, 2013, Pages 923-932

  Dobler, Claudia C ^a,b   Waterer, Grant ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

community acquired pneumonia; drug resistant pathogen; health care associated pneumonia; hospital acquired pneumonia; inappropriate antibiotic therapy

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ASIA; COMMUNITY ACQUIRED PNEUMONIA; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FUNCTIONAL STATUS; GRAM NEGATIVE BACTERIUM; HEALTH CARE ASSOCIATED PNEUMONIA; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; MEDICAL TERMINOLOGY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; UNITED STATES;

COMMUNITY-ACQUIRED PNEUMONIA; DRUG-RESISTANT PATHOGEN; HEALTH CARE-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; INAPPROPRIATE ANTIBIOTIC THERAPY;

ANTI-BACTERIAL AGENTS; ASIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; PACIFIC ISLANDS; PNEUMONIA; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 84880819409     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12132     Document Type: Review

References (71)

1. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 388-416.
2. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 2002; 137: 791-797.
3. Weinstein MP, Reller LB, Murphy JR, et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev. Infect. Dis. 1983; 5: 35-53.
4. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 1997; 24: 584-602.
5. Morin CA, Hadler JL,. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J. Infect. Dis. 2001; 184: 1029-1034.
6. Tambyah PA, Habib AG, Ng TM, et al. Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually 'healthcare associated'. Infect. Control Hosp. Epidemiol. 2003; 24: 436-438.
7. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128: 3854-3862.
8. El-Solh AA, Sikka P, Ramadan F, et al. Etiology of severe pneumonia in the very elderly. Am. J. Respir. Crit. Care Med. 2001; 163: 645-651.
9. El-Solh AA, Aquilina AT, Dhillon RS, et al. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am. J. Respir. Crit. Care Med. 2002; 166: 1038-1043.
10. Venkatesan P, Gladman J, Macfarlane JT, et al. A hospital study of community acquired pneumonia in the elderly. Thorax 1990; 45: 254-258.
11. Riquelme R, Torres A, El-Ebiary M, et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am. J. Respir. Crit. Care Med. 1996; 154: 1450-1455.
12. Zalacain R, Torres A, Celis R, et al. Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur. Respir. J. 2003; 21: 294-302.
13. Lim WS, Macfarlane JT,. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur. Respir. J. 2001; 18: 362-368.
14. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin. Microbiol. Infect. 2011; 17 (Suppl. 6): E1-59.
15. Niederman MS, Luna CM,. Community-acquired pneumonia guidelines: a global perspective. Semin. Respir. Crit. Care Med. 2012; 33: 298-310.
16. Craven DE, Palladino R, McQuillen DP,. Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect. Dis. Clin. North Am. 2004; 18: 939-962.
17. Chroneou A, Zias N, Beamis JF, Jr, et al. Healthcare-associated pneumonia: principles and emerging concepts on management. Expert. Opin. Pharmacother. 2007; 8: 3117-3131.
18. Abrahamian FM, Deblieux PM, Emerman CL, et al. Health care-associated pneumonia: identification and initial management in the ED. Am. J. Emerg. Med. 2008; 26: 1-11.
19. Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP Summit. Clin. Infect. Dis. 2008; 46 (Suppl. 4): S296-334; quiz 5-8.
20. Zilberberg MD, Shorr AF,. Epidemiology of healthcare-associated pneumonia (HCAP). Semin. Respir. Crit. Care Med. 2009; 30: 10-15.
21. Poch DS, Ost DE,. What are the important risk factors for healthcare-associated pneumonia? Semin. Respir. Crit. Care Med. 2009; 30: 26-35.
22. Polverino E, Torres A,. Diagnostic strategies for healthcare-associated pneumonia. Semin. Respir. Crit. Care Med. 2009; 30: 36-45.
23. Slaven EM, Santanilla JI, DeBlieux PM,. Healthcare-associated pneumonia in the emergency department. Semin. Respir. Crit. Care Med. 2009; 30: 46-51.
24. Lam AP, Wunderink RG,. The role of MRSA in healthcare-associated pneumonia. Semin. Respir. Crit. Care Med. 2009; 30: 52-60.
25. Restrepo MI, Anzueto A,. The role of gram-negative bacteria in healthcare-associated pneumonia. Semin. Respir. Crit. Care Med. 2009; 30: 61-66.
26. Forgie S, Marrie TJ,. Healthcare-associated atypical pneumonia. Semin. Respir. Crit. Care Med. 2009; 30: 67-85.
27. Morrow LE,. Prevention strategies for healthcare-associated pneumonia. Semin. Respir. Crit. Care Med. 2009; 30: 86-91.
28. Neuner EA, Ritchie DJ, Micek ST,. New antibiotics for healthcare-associated pneumonia. Semin. Respir. Crit. Care Med. 2009; 30: 92-101.
29. Polverino E, Torres A,. Current perspective of the HCAP problem: is it CAP or is it HAP? Semin. Respir. Crit. Care Med. 2009; 30: 239-248.
30. Ewig S, Welte T, Chastre J, et al. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect. Dis. 2010; 10: 279-287.
31. Brito V, Niederman MS,. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr. Opin. Infect. Dis. 2009; 22: 316-325.
32. Attridge RT, Frei CR,. Health care-associated pneumonia: an evidence-based review. Am. J. Med. 2011; 124: 689-697.
33. Ewig S, Welte T, Torres A,. Is healthcare-associated pneumonia a distinct entity needing specific therapy? Curr. Opin. Infect. Dis. 2012; 25: 166-175.
34. Micek ST, Kollef KE, Reichley RM, et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob. Agents Chemother. 2007; 51: 3568-3573.
35. Carratala J, Mykietiuk A, Fernandez-Sabe N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch. Intern. Med. 2007; 167: 1393-1399.
36. Garcia-Vidal C, Viasus D, Roset A, et al. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin. Microbiol. Infect. 2011; 17: 1659-1665.
37. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009; 135: 633-640.
38. Umeki K, Tokimatsu I, Yasuda C, et al. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirology 2011; 16: 856-861.
39. Park HK, Song JU, Um SW, et al. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir. Med. 2010; 104: 1729-1735.
40. Jung JY, Park MS, Kim YS, et al. Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital. BMC Infect. Dis. 2011; 11: 61. doi: 10.1186/1471-2334-11-61
41. Venditti M, Falcone M, Corrao S, et al. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann. Intern. Med. 2009; 150: 19-26.
42. Rello J, Lujan M, Gallego M, et al. Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest 2010; 137: 1138-1144.
43. Shorr AF, Zilberberg MD, Micek ST, et al. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch. Intern. Med. 2008; 168: 2205-2210.
44. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Arch. Intern. Med. 2002; 162: 1849-1858.
45. Lescure FX, Locher G, Eveillard M, et al. Community-acquired infection with healthcare-associated methicillin-resistant Staphylococcus aureus: the role of home nursing care. Infect. Control Hosp. Epidemiol. 2006; 27: 1213-1218.
46. Maruyama T, Niederman MS, Kobayashi T, et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir. Med. 2008; 102: 1287-1295.
47. El Solh AA, Pietrantoni C, Bhat A, et al. Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin. Infect. Dis. 2004; 39: 474-480.
48. Marrie TJ, Wu L,. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005; 127: 1260-1270.
49. Schreiber MP, Chan CM, Shorr AF,. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest 2010; 137: 1283-1288.
50. Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin. Infect. Dis. 2011; 53: 107-113.
51. El Solh AA, Akinnusi ME, Alfarah Z, et al. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia. J. Am. Geriatr. Soc. 2009; 57: 1030-1035.
52. Grenier C, Pepin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J. Antimicrob. Chemother. 2011; 66: 1617-1624.
53. Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur. Respir. J. 2011; 38: 878-887.
54. Kett DH, Cano E, Quartin AA, et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect. Dis. 2011; 11: 181-189.
55. Loeb M, Carusone SC, Goeree R, et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA 2006; 295: 2503-2510.
56. Paladino JA, Eubanks DA, Adelman MH, et al. Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia. J. Am. Geriatr. Soc. 2007; 55: 651-657.
57. Yakovlev SV, Stratchounski LS, Woods GL, et al. Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit. Eur. J. Clin. Microbiol. Infect. Dis. 2006; 25: 633-641.
58. Komiya K, Ishii H, Umeki K, et al. Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: a multicenter retrospective cohort study. Respirology 2013; 18: 514-521.
59. Taylor SP, Taylor BT,. Health care-associated pneumonia in haemodialysis patients: clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy. Respirology 2013; 18: 364-368.
60. Seki M, Hashiguchi K, Tanaka A, et al. Characteristics and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu, Japan. J. Infect. Chemother. 2011; 17: 363-369.
61. Sugisaki M, Enomoto T, Shibuya Y, et al. Clinical characteristics of healthcare-associated pneumonia in a public hospital in a metropolitan area of Japan. J. Infect. Chemother. 2012; 18: 352-360.
62. Jeon EJ, Cho SG, Shin JW, et al. The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea. Yonsei Med. J. 2011; 52: 282-287.
63. Hoo Lee J, Hyung Kim Y,. Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals. Braz. J. Infect. Dis. 2012; 16: 321-328.
64. Wu CL, Ku SC, Yang KY, et al. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan. J. Formos. Med. Assoc. 2013; 112: 31-40.
65. Oshitani Y, Nagai H, Matsui H, et al. Reevaluation of the Japanese guideline for healthcare-associated pneumonia in a medium-sized community hospital in Japan. J. Infect. Chemother. 2012. doi: 10.1007/s10156-012-0517-1
66. The committee for the Japanese Respiratory Society guidelines for the management of nursing and healthcare-associated pneumonia. The Japanese Respiratory Society Guidelines for the Management of Nursing and Healthcare-Associated Pneumonia. The Japanese Respiratory Society, Tokyo, 2011. Article in Japanese.
67. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 1982; 5: 649-655.
68. Fukuyama H, Yamashiro S, Tamaki H, et al. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J. Infect. Chemother. 2013. doi: 10.1007/s10156-013-0557-1
69. Kaku N, Yanagihara K, Morinaga Y, et al. The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP). J. Infect. Chemother. 2013; 19: 70-76.
70. Miyashita N, Kawai Y, Akaike H, et al. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med 2012; 51: 585-594.
71. Ishida T, Tachibana H, Ito A, et al. Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia. Intern Med. 2012; 51: 2537-2544.